tiprankstipranks
Advertisement
Advertisement

LMAT Stock Latest News

LMAT Upcoming Earnings Report: What to Expect?
Pre-EarningsLMAT Upcoming Earnings Report: What to Expect?
24h ago
LMAT
LeMaitre Vascular Announces Board Changes and Size Reduction
PremiumCompany Announcements
LeMaitre Vascular Announces Board Changes and Size Reduction
20d ago
8K
LMAT
LeMaitre initiated with a Hold at Freedom Capital
PremiumThe Fly
LeMaitre initiated with a Hold at Freedom Capital
1M ago
LMAT
LeMaitre Vascular Signals Confident Growth in Earnings Call
PremiumCompany Announcements
LeMaitre Vascular Signals Confident Growth in Earnings Call
2M ago
LMAT
LeMaitre price target raised to $105 from $95 at Barrington
PremiumThe Fly
LeMaitre price target raised to $105 from $95 at Barrington
2M ago
LMAT
LeMaitre price target raised to $117 from $108 at Roth Capital
PremiumThe FlyLeMaitre price target raised to $117 from $108 at Roth Capital
2M ago
LMAT
LeMaitre price target raised to $118 from $113 at Citizens
Premium
The Fly
LeMaitre price target raised to $118 from $113 at Citizens
2M ago
LMAT
LeMaitre reports Q4 EPS 68c, consensus 66c
Premium
The Fly
LeMaitre reports Q4 EPS 68c, consensus 66c
2M ago
LMAT
LeMaitre sees Q1 EPS 64c-69c, consensus 61c
PremiumThe Fly
LeMaitre sees Q1 EPS 64c-69c, consensus 61c
2M ago
LMAT
LeMaitre sees FY26 EPS $2.81-$3.01, consensus $2.59
PremiumThe Fly
LeMaitre sees FY26 EPS $2.81-$3.01, consensus $2.59
2M ago
LMAT
LMAT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LMAT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
LMAT
LeMaitre Vascular’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
LeMaitre Vascular’s Earnings Call: Growth Amid Challenges
6M ago
LMAT
LeMaitre Vascular’s Strong Financial Performance and Growth Prospects Justify Buy Rating and OUTPERFORM Status
PremiumRatingsLeMaitre Vascular’s Strong Financial Performance and Growth Prospects Justify Buy Rating and OUTPERFORM Status
6M ago
LMAT
LeMaitre Vascular Reports Strong Q3 2025 Financial Growth
Premium
Company Announcements
LeMaitre Vascular Reports Strong Q3 2025 Financial Growth
6M ago
LMAT
LeMaitre reports Q3 adjusted EPS 62c consensus 56c
Premium
The Fly
LeMaitre reports Q3 adjusted EPS 62c consensus 56c
6M ago
LMAT
LeMaitre sees Q4 EPS 64c-69c, consensus 63c
PremiumThe Fly
LeMaitre sees Q4 EPS 64c-69c, consensus 63c
6M ago
LMAT
LeMaitre sees FY25 EPS $2.48-$2.53, consensus $2.28
PremiumThe Fly
LeMaitre sees FY25 EPS $2.48-$2.53, consensus $2.28
6M ago
LMAT
LeMaitre resumed with a Buy at Roth Capital
PremiumThe Fly
LeMaitre resumed with a Buy at Roth Capital
6M ago
LMAT
LMAT Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LMAT Earnings this Week: How Will it Perform?
6M ago
LMAT
Lemaitre Vascular: Strong Pricing Power and Strategic Growth Opportunities Support Buy Rating
PremiumRatingsLemaitre Vascular: Strong Pricing Power and Strategic Growth Opportunities Support Buy Rating
7M ago
LMAT
LeMaitre expects no impact from warning letter, says Wells Fargo
Premium
The Fly
LeMaitre expects no impact from warning letter, says Wells Fargo
8M ago
LMAT
FDA posts warning letter sent to LeMaitre over site violations
Premium
The Fly
FDA posts warning letter sent to LeMaitre over site violations
8M ago
LMAT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >